Results 101 to 110 of about 1,327 (186)

Advances in migraine treatment - a review [PDF]

Introduction Migraine is a heavily debilitating disease  that ranks second place in Global Burden Disease. It is estimated that around 1 billion of people suffer from it. It also has a significant negative impact on health-related quality of life (HRQoL)
Frańczuk, Agata, Grzelka, Michalina, Głoskowska, Julia, Kejna, Paulina, Kopczyńska, Ewelina, Kuleta, Katarzyna, Makłowicz, Aleksandra, Szpulak, Angelika, Słychan, Katarzyna, Łęska, Aleksandra Elżbieta   +9 more
core   +1 more source

MONOCLONAL ANTIBODIES TARGETING CGRP IN MIGRAINE: CURRENT PERSPECTIVES AND CLINICAL GUIDELINES [PDF]

Aim: This review aims to explore the clinical relevance and therapeutic potential of monoclonal antibodies targeting the calcitonin gene-related peptide (CGRP) pathway in the preventive treatment of migraine.
Agnieszka Szczerbińska, Jan Kamiński, Julia Błoniecka, Julia Dolinkiewicz, Sebastian Rurka   +4 more
core   +2 more sources

Safety of Rimegepant in Adults with Migraine and Cardiovascular Risk Factors: Analysis of a Multicenter, Long-Term, Open-Label Study

Pain and Therapy
Introduction Cardiovascular (CV) risk factors can limit treatment options for migraine. Rimegepant is an orally administered small-molecule calcitonin gene-related peptide receptor antagonist that does not induce vasoconstriction.
David True, Kathleen Mullin, Robert Croop   +2 more
doaj   +1 more source

Efficacy of lasmiditan, rimegepant and ubrogepant for acute treatment of migraine in triptan insufficient responders: systematic review and network meta-analysis

The Journal of Headache and Pain
Background Novel abortive treatments for migraine, ditans and gepants, have promising implications in triptan-insufficient responders with minimal existing comparative data.
Wattakorn Laohapiboolrattana, Priabprat Jansem, Prakit Anukoolwittaya, Duangnapa Roongpiboonsopit, Akarin Hiransuthikul, Thanakit Pongpitakmetha, Sekh Thanprasertsuk, Wanakorn Rattanawong   +7 more
doaj   +1 more source

Comparative Efficacy, Quality of Life, Safety, and Tolerability of Atogepant and Rimegepant in Migraine Prevention: A Matching-Adjusted Indirect Comparison Analysis [PDF]

BACKGROUND: Comparative evaluations of preventive migraine treatments can help inform clinical decision making for managing migraine in clinical practice.
Ailani, Jessica, Duan, Molly, Dupont-Benjamin, Laure, Gandhi, Pranav, Halker Singh, Rashmi B., Hemstock, Matthew, McAllister, Peter, Nahas, Stephanie J., Onishchenko, Kateryna, Tassorelli, Cristina, Voller, Corey   +10 more
core   +1 more source

Safety of Rimegepant in Patients Using Preventive Migraine Medications: A Subgroup Analysis of a Long-Term, Open-Label Study Conducted in the United States

Journal of Pain Research
Gary Berman,1 Alexandra Thiry,2 Robert Croop3 1Clinical Research Institute, Minneapolis, MN, USA; 2Pfizer Inc., New York, NY, USA; 3Biohaven Pharmaceuticals, New Haven, CT, USACorrespondence: Gary Berman, Clinical Research Institute, 825 Nicollet Mall ...
Berman G, Thiry A, Croop R
doaj  

Rimegepant Sulfate

American Journal of Health-System Pharmacy, 2020
openaire   +1 more source

Rimegepant for migraine: acute efficacy beyond the USA

The Lancet Neurology, 2023
openaire   +3 more sources

The Most Current and Effective Pharmaceutical Treatment Options for Chronic Migraines [PDF]

Chronic migraine (CM) is a debilitating condition that affects a significant portion of the population. Treatment for CM is a current area of research with new medications being developed. One of the latest mechanisms of action for treatment is targeting
Hall, Hannah, Riley, Sophia, Van Otterloo, Jill, Wright, Sierra   +3 more
core   +1 more source

Strategies for Treating Acute Migraines and Identifying Triggers. Literature review [PDF]

Introduction Migraine, a prevalent neurological disorder affecting a substantial portion of the global population, poses a significant burden on individuals' overall quality of life.
Bogusz, Aleksander, Górecka, Sandra, Kotowicz, Zuzanna, Kołodziej, Anna, Król, Anita, Kwiatkowski, Oskar, Olszański, Miłosz, Pabiś, Jakub, Podgórski, Piotr   +8 more
core   +1 more source